GL1X · GenesisL1 explorer

MolNFT v1 · #54432 · protein

Functional and structural analyses of N-acylsulfonamide- linked dinucleoside inhibitors of ribonuclease a

2XOI · Ribonuclease pancreatic: “Functional and structural analyses of N-acylsulfonamide- linked dinucleoside inhibitors of ribonuclease a”. X-ray diffraction, 1 ligand (SFB), 2 pockets (best druggability 0.49). MolNFT v1 #54432 on…

PDB
2XOI
Type
protein
Length
245 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Ribonuclease pancreatic
EC
3.1.27.5
UniProt
P61823
Ligands
SFB
Pockets
2 · best druggability 0.49

Structure

x-ray diffraction · 2 distinct chains · 21% helix, 36% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ARibonuclease pancreatic (EC 3.1.27.5)protein12321% helix, 36% strandP61823
BRibonuclease pancreatic (EC 3.1.27.5)protein12221% helix, 36% strandP61823

Ligands and binding sites

  • SFB · (2S,3S,4R,5R)-5-(6-aminopurin-9-yl)-N-[[(2S,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl]methylsulfonyl]-3,4-dihydroxy-oxolane-2-carboxamide · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11970.490.7629empty
2610.360.7813empty

Interfaces

1 interface between chains.

  • A–B · 330 Ų buried · 5 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 8 disulfide (disulfide).

Compared structures

  • 2XOI · Functional and Structural Analyses of N-Acylsulfonamide-Linked Dinucleoside Inhibitors of… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.